Efficacy of Dulaglutide in Chinese Patients with Type 2 Diabetes and Different Glycemic Patterns: a Post-hoc Analysis of the Phase 3 AWARD-CHN2 Trial
Sign Up to like & getrecommendations! Published in 2021 at "Diabetes Therapy"
DOI: 10.1007/s13300-021-01182-z
Abstract: Introduction We evaluated the effect of dulaglutide on the relative contributions of fasting glucose (FG) and postprandial glucose (PPG) to overall hyperglycemia in patients with type 2 diabetes (T2D), and assessed responses to dulaglutide versus… read more here.
Keywords: type diabetes; relative contributions; ppg; glargine ... See more keywords
Effects of dapagliflozin and/or insulin glargine on beta cell mass and hepatic steatosis in db/db mice.
Sign Up to like & getrecommendations! Published in 2019 at "Metabolism: clinical and experimental"
DOI: 10.1016/j.metabol.2019.06.006
Abstract: OBJECTIVE To explore the beneficial effects of dapagliflozin and/or insulin glargine on the pancreatic beta cell mass and hepatic steatosis in db/db mice. METHODS Six-week-old db/db mice were assigned to one of four groups: untreated… read more here.
Keywords: glargine; cell mass; insulin glargine; gla ... See more keywords
Cost Effectiveness of Dulaglutide Compared with Liraglutide and Glargine in Type 2 Diabetes Mellitus Patients in Colombia.
Sign Up to like & getrecommendations! Published in 2017 at "Value in health regional issues"
DOI: 10.1016/j.vhri.2016.10.006
Abstract: BACKGROUND Diabetes treatment includes very diverse drugs. It is essential to identify which drugs offer the best value for their costs. OBJECTIVES To estimate comparative cost effectiveness for treating diabetes mellitus with dulaglutide, liraglutide, or… read more here.
Keywords: glargine; liraglutide glargine; cost; diabetes mellitus ... See more keywords
Efficacy and safety of insulin detemir versus glargine in patients with diabetes: a systematic review and meta-analysis
Sign Up to like & getrecommendations! Published in 2022 at "Expert Review of Clinical Pharmacology"
DOI: 10.1080/17512433.2022.2078700
Abstract: ABSTRACT Objectives Performing an updated meta-analysis to compare the safety and efficacy of insulin glargine and insulin detemir in adults with type 1 and type 2 diabetes. Methods Electronic databases were searched up to 18… read more here.
Keywords: glargine; type diabetes; meta analysis; insulin detemir ... See more keywords
Higher Derived Time in Range With IDegLira Versus Insulin Glargine U100 in People With Type 2 Diabetes.
Sign Up to like & getrecommendations! Published in 2023 at "Journal of diabetes science and technology"
DOI: 10.1177/19322968221149041
Abstract: BACKGROUND Derived time in range (dTIR), calculated from self-monitored blood glucose (SMBG-dTIR) profiles, has demonstrated correlation with risk of cardiovascular and microvascular complications. This post hoc analysis of the DUAL V and DUAL VIII trials… read more here.
Keywords: dual viii; glargine u100; range; glargine ... See more keywords
SUN-171 Glargine Use in a Neonatal Diabetic
Sign Up to like & getrecommendations! Published in 2019 at "Journal of the Endocrine Society"
DOI: 10.1210/js.2019-sun-171
Abstract: Abstract BACKGROUND Neonatal Diabetes (ND) is rare with incidence estimated at 1 / 100,000-500,000 live births. Duration of ND and insulin requirements vary with average therapy lasting 3 months. Genetic mutations are reported in 90%… read more here.
Keywords: continuous insulin; glargine; insulin; insulin infusion ... See more keywords
United States experience of insulin degludec alone or in combination for type 1 and type 2 diabetes
Sign Up to like & getrecommendations! Published in 2017 at "Drug Design, Development and Therapy"
DOI: 10.2147/dddt.s132581
Abstract: Insulin degludec has been the product of a sophisticated and systematic biochemical engineering program which began with the release of insulin detemir. The goal was to produce a long-lasting basal insulin with low individual variability.… read more here.
Keywords: insulin; glargine; type diabetes; degludec alone ... See more keywords
Safety and efficacy of GP40061 compared with originator insulin glargine (Lantus®): a randomized open-label clinical trial.
Sign Up to like & getrecommendations! Published in 2020 at "Journal of comparative effectiveness research"
DOI: 10.2217/cer-2019-0136
Abstract: Aim: To compare safety (immunogenicity) and efficacy of GP40061 insulin glargine (GP-Gla) and Lantus® (Sanofi glargine, Sa-Gla) in people with diabetes mellitus. Materials & methods: This randomized open-label, 26-week clinical trial enrolled 180 Type 1… read more here.
Keywords: insulin; glargine; efficacy gp40061; safety ... See more keywords